ProPhase Labs, Inc.
PRPH
$0.05
$0.0120.05%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -24.06M | -14.74M | -41.70M | -41.45M | -43.13M |
| Total Depreciation and Amortization | 4.42M | 5.06M | 5.74M | 6.32M | 6.53M |
| Total Amortization of Deferred Charges | 5.34M | 5.24M | 2.32M | 1.97M | 1.72M |
| Total Other Non-Cash Items | 4.32M | -3.71M | 9.06M | 7.71M | 5.73M |
| Change in Net Operating Assets | 4.27M | -185.00K | 13.96M | 14.27M | 13.37M |
| Cash from Operations | -5.71M | -8.34M | -10.63M | -11.18M | -15.78M |
| Capital Expenditure | -- | -- | -40.00K | -39.00K | -39.00K |
| Sale of Property, Plant, and Equipment | 79.00K | 120.00K | 120.00K | 199.00K | 282.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 800.00K | 800.00K | 623.00K | 597.00K |
| Cash from Investing | 79.00K | 920.00K | 880.00K | 783.00K | 840.00K |
| Total Debt Issued | 8.05M | 7.57M | 7.94M | 7.18M | 7.61M |
| Total Debt Repaid | -2.80M | -4.26M | -5.77M | -5.87M | -5.57M |
| Issuance of Common Stock | 321.00K | 3.56M | 6.53M | 6.53M | 10.87M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -35.00K | 959.00K | 953.00K | 947.00K |
| Cash from Financing | 5.58M | 6.84M | 9.66M | 8.79M | 13.85M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -57.00K | -588.00K | -96.00K | -1.61M | -1.09M |